Cholesteatoma aggressiveness in paediatric vs. adult patients: a comparative analysis of molecular markers with MERI and EAONO/JS staging
- 21 March 2025
- journal article
- research article
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 282 (8) , 3991-3999
Abstract
Purpose Cholesteatoma is characterized by the abnormal growth of keratinizing squamous epithelium in the middle ear. Although both pediatric and adult populations are affected, differences in the molecular mechanisms underlying cholesteatoma between these age groups are not fully understood. miRNA-21 and IL-6 have been implicated in various inflammatory and proliferative processes, and their roles in cholesteatoma pathogenesis among different age groups warrant detailed investigation. Research objective -Compare the expression levels of miRNA-21 and IL-6 genes in pediatric versus adult cholesteatoma tissues to elucidate potential age-related molecular differences. Methods Tissue samples were collected from 30 patients (15 in Pediatric group and 15 in Adult group) undergoing surgical treatment for cholesteatoma. Preoperative MERI scores and Quantitative real-time PCR (qRT-PCR) was employed to measure the expression levels of miRNA-21 and IL-6. Statistical analyses were conducted to compare the expression profiles between the two groups. Results The results revealed a significantly higher expression of miRNA-21 and IL-6 in pediatric cholesteatoma compared to adult cholesteatoma. These findings suggest distinct molecular pathways may be involved in the pathogenesis of cholesteatoma in different age groups. Conclusion The differential expression of miRNA-21 and IL-6 between pediatric and adult cholesteatoma underscores the potential for age-specific therapeutic targets. Increased miRNA-21 and IL-6 gene expression in pediatric cases may indicate a more pronounced role in tissue proliferation and inflammation. Further research is necessary to explore the clinical implications and potential for targeted treatments based on these molecular differences. Level of Evidence 3.Keywords
This publication has 20 references indexed in Scilit:
- EAONO/JOS Joint Consensus Statements on the Definitions, Classification and Staging of Middle Ear CholesteatomaThe Journal of International Advanced Otology, 2019
- Surgical management of primary parapharyngeal space tumors: a 10-year reviewActa Oto-Laryngologica, 2016
- Surgical management of middle ear cholesteatoma and reconstruction at the same timeColombia Medica, 2014
- Activation of the IL-6/JAK/STAT3 signaling pathway in human middle ear cholesteatoma epithelium.2014
- Aggressiveness of Pediatric Cholesteatoma. Do We Have an Evidence?Indian Journal of Otolaryngology and Head & Neck Surgery, 2012
- Post-Transcriptional Regulation by MicroRNA-21 and let-7a MicroRNA in Paediatric CholesteatomaJournal of International Medical Research, 2011
- Childhood cholesteatomaEuropean Annals of Otorhinolaryngology, Head and Neck Diseases, 2010
- Cholesteatoma Growth and ProliferationOtology & Neurotology, 2009
- Evaluation of prognostic factors and middle ear risk index in tympanoplastyOtolaryngology–Head and Neck Surgery, 2008
- Role of interleukin 6 in epithelial hyperproliferation and bone resorption in middle ear cholesteatomasEuropean Archives of Oto-Rhino-Laryngology, 1996